The drug Heberprot-P continues is still the only one of its kind and very effective, 17 years after its registration in the Cuban health registry, on June 8, 2006.»
HEBERPROT-P
Sancti Spíritus Deepens Investigation on Heberprot-P Efficacy
A unique investigation is underway in Sancti Spiritus, central Cuba, to provide new evidence on the efficacy of this drug»
Cuban Biopharmaceutical Industry Limited due to US Blockade
The biopharmaceutical industry is one of the country's strategic economic sectors»
Mexico Registers Cuban Medication for Diabetic Patients
The registration of the pharmaceutical was announced in Havana in the first meeting of the Mexico-Cuba Health Cooperation Group»
Heberprot-p Might Soon Be Available for US Patients
According to BioCubaFarma enterprise, it is hoped that the Cuban developed medication will soon be available for patients in the United States»
Heberprot-P Treatment Benefits Thousands in Cuba
Heberprot-p was created by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB)»
Cuba, Russia Discuss Increasing Public Health Cooperation
The next meeting of the Russia-Cuba Health Working Group Intergovernmental Commission will be held in May»
Cuba’s Heberprot-P Granted Health Registration in 23 Countries
Unique in the world to treat advanced foot ulcers in diabetic patients, the Cuban drug Heberprot-P has already been registered in 23 countries, it was informed today»
Cuba Hosts Congress on Diabetes
Specialists from at least 40 countries will assist to the International Congress “Controlling diabetes and its most severe complications”, to take place December 10th to 12th, in Varadero. »
Over 31,000 Cuban Patients Benefit from Heberprot-P
Cuba reduced by over 78 percent the relative risk of amputation due to diabetic foot ulcers, thanks to a comprehensive program of care for these patients that includes the use of the drug Heberprot-P.»